These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16267944)

  • 1. Microvolt T-wave alternans testing to risk stratify patients being considered for ICD therapy for primary prevention of sudden death.
    Technol Eval Cent Assess Program Exec Summ; 2005 Oct; 20(9):1-3. PubMed ID: 16267944
    [No Abstract]   [Full Text] [Related]  

  • 2. Microvolt T-wave alternans testing to risk stratify patients being considered for ICD therapy for primary prevention of sudden death.
    Blue Cross Blue Shield Association Technology Evaluation Center
    Technol Eval Cent Assess Program Exec Summ; 2007 May; 21(14):1-3. PubMed ID: 17557413
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia.
    Technol Eval Cent Assess Program Exec Summ; 2005 Mar; 19(19):1-6. PubMed ID: 15793938
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia.
    TEC Bull (Online); 2002 Jul; 19(2):29-36. PubMed ID: 12166476
    [No Abstract]   [Full Text] [Related]  

  • 5. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
    Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The microvolt T-wave alternans test].
    Görmez S; Erciyes D; Gülbaran M
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):436-43. PubMed ID: 21200127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
    Chauhan VS; Selvaraj RJ
    Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification.
    Chow T; Joshi D
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):833-42. PubMed ID: 18570621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death].
    Yang P; Guo T; Tang YM; Zhao L; Li SM; Liu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):517-22. PubMed ID: 19100065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T wave alternans: a marker of myocardial instability.
    Harvey M; Malkin R
    Prog Cardiovasc Nurs; 2003; 18(2):99-107, 111. PubMed ID: 12732803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
    Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden cardiac death and implantable cardioverter-defibrillators.
    Turakhia MP
    Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death: the role of risk stratification.
    Kusmirek SL; Gold MR
    Am Heart J; 2007 Apr; 153(4 Suppl):25-33. PubMed ID: 17394900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
    Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    De Ferrari GM; Verrier RL
    Circulation; 2009 Jul; 120(3):e20; author reply e22. PubMed ID: 19620521
    [No Abstract]   [Full Text] [Related]  

  • 18. Microvolt T-wave alternans for the risk stratification of dangerous ventricular arrhythmias in patients with previously implanted automatic cardioverter-defibrillator.
    Lewandowski M; Kossuth I; Zielonka J; Wielusiński M; Kazimierczak A; Kornacewicz Jach Z; Przybycień K; Kaliszczak R
    Kardiol Pol; 2011; 69(6):580-5. PubMed ID: 21678296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention.
    Daccarett M; Serafimovski N; Machado C
    Int J Cardiol; 2007 Jun; 119(1):127-8; author reply 129-30. PubMed ID: 17049385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.